Terms: = Gastric cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
19 results:
1. The clinical importance of the host anti-tumour reaction patterns in regional tumour draining lymph nodes in patients with locally advanced resectable gastric cancer: a systematic review and meta-analysis.
Budginaite E; Kloft M; van Kuijk SMJ; Canao PA; Kooreman LFS; Pennings AJ; Magee DR; Woodruff HC; Grabsch HI
Gastric Cancer; 2023 Nov; 26(6):847-862. PubMed ID: 37776394
[TBL] [Abstract] [Full Text] [Related]
2. Celastrol impairs tumor growth by modulating the CIP2A-GSK3β-mcl-1 axis in gastric cancer cells.
Wu J; Ye F; Xu T
Aging (Albany NY); 2023 Jul; 15(14):6894-6904. PubMed ID: 37470692
[TBL] [Abstract] [Full Text] [Related]
3. Dynamic Nomogram for Predicting Long-Term Survival in Terms of Preoperative and Postoperative Radiotherapy Benefits for Advanced gastric cancer.
Li X; Yu Y; Zheng C; Zhang Y; Shi C; Zhang L; Qiao H
Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36768111
[TBL] [Abstract] [Full Text] [Related]
4. Expression and Potential Prognostic Value of SOX9, mcl-1 and SPOCK1 in gastric Adenocarcinoma.
Luo W; Nagaria TS; Sun H; Ma J; Lombardo JL; Bassett R; Cao AC; Tan D
Pathol Oncol Res; 2022; 28():1610293. PubMed ID: 35221802
[TBL] [Abstract] [Full Text] [Related]
5. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.
Jin K; Cao Y; Gu Y; Fang H; Fei Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Xu J
Oncoimmunology; 2021 Apr; 10(1):1915560. PubMed ID: 33996266
[TBL] [Abstract] [Full Text] [Related]
6. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
Song S; Chen Q; Li Y; Lei G; Scott A; Huo L; Li CY; Estrella JS; Correa A; Pizzi MP; Ma L; Jin J; Liu B; Wang Y; Xiao L; Hofstetter WL; Lee JH; Weston B; Bhutani M; Shanbhag N; Johnson RL; Gan B; Wei S; Ajani JA
Gut; 2021 Dec; 70(12):2238-2248. PubMed ID: 33487592
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
[TBL] [Abstract] [Full Text] [Related]
8. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
9. Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
Yu HE; Wang F; Yu F; Zeng ZL; Wang Y; Lu YX; Jin Y; Wang DS; Qiu MZ; Pu HY; Kang TB; Xie D; Ju HQ; Xu RH; Luo HY
Cell Death Dis; 2019 May; 10(6):413. PubMed ID: 31138787
[TBL] [Abstract] [Full Text] [Related]
10. Micheliolide inhibits gastric cancer growth
Tang X; Ding Q; Chen C; Chen F; Zhou X; Hong CJ; Pan W
Pharmazie; 2019 Mar; 74(3):175-178. PubMed ID: 30961685
[TBL] [Abstract] [Full Text] [Related]
11. Inhibitory effects of isocryptotanshinone on gastric cancer.
Chen ZM; Huang L; Li MM; Meng L; Ying SC; Xu AM
Sci Rep; 2018 Jun; 8(1):9307. PubMed ID: 29915371
[TBL] [Abstract] [Full Text] [Related]
12. Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer.
Lee WS; Park YL; Kim N; Oh HH; Son DJ; Kim MY; Oak CY; Chung CY; Park HC; Kim JS; Myung DS; Cho SB; Joo YE
Int J Oncol; 2015 May; 46(5):2154-62. PubMed ID: 25672320
[TBL] [Abstract] [Full Text] [Related]
13. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene mcl-1 in gastric cancer cells.
Hu CJ; Wang B; Tang B; Chen BJ; Xiao YF; Qin Y; Yong X; Luo G; Zhang JW; Zhang D; Li S; He F; Yang SM
Biochim Biophys Acta; 2015 Mar; 1849(3):290-9. PubMed ID: 25482013
[TBL] [Abstract] [Full Text] [Related]
14. Endoscopic findings in mantle cell lymphoma with gastrointestinal tract involvement.
Kim JH; Jung HW; Kang KJ; Min BH; Lee JH; Chang DK; Kim YH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim SJ; Kim WS; Ko YH; Kim JY
Acta Haematol; 2012; 127(3):129-34. PubMed ID: 22236942
[TBL] [Abstract] [Full Text] [Related]
15. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China.
Gao Y; Hu N; Han X; Giffen C; Ding T; Goldstein A; Taylor P
BMC Cancer; 2009 Aug; 9():269. PubMed ID: 19656375
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic role of myeloid cell leukemia-1 protein (mcl-1) expression in human gastric cancer.
Likui W; Qun L; Wanqing Z; Haifeng S; Fangqiu L; Xiaojun L
J Surg Oncol; 2009 Oct; 100(5):396-400. PubMed ID: 19582795
[TBL] [Abstract] [Full Text] [Related]
17. Synchronous adenocarcinoma and mantle cell lymphoma of the stomach.
Kim YI; Koo MY
Yonsei Med J; 2007 Dec; 48(6):1061-5. PubMed ID: 18159604
[TBL] [Abstract] [Full Text] [Related]
18. mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells.
Wacheck V; Cejka D; Sieghart W; Losert D; Strommer S; Crevenna R; Monia BP; Selzer E
Cancer Biol Ther; 2006 Oct; 5(10):1348-54. PubMed ID: 16969094
[TBL] [Abstract] [Full Text] [Related]
19. Expression of mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
[TBL] [Abstract] [Full Text] [Related]